Dr Eckel Animal Nutrition GmbH & Co. KG, Germany, a global animal nutrition specialist company organised World Tour 2026 Conference at Hotel Avani Riverside, Bangkok on March 14, 2026 which was attended by 90 over delegates from 12 countries which was addressed by eminent speakers.

In the year 1994, Dr. Antje Eckel, CEO, founded the company Dr. Eckel Animal Nutrition, aimed at ensuring animal nutrition is healthier, more animal-friendly and more sustainable. Over the next three decades, the family business grew into a globally successful provider of alternative animal feeding solutions. Other key persons associated with the company are Dr. Bernhard Eckel, Vice President – Sales, Dr. Viktor Eckel, Managing Director-Products and Innovation, Mr. Theo Eckel Head-Purchase and Ms. Klara Eckel, Product Manager.

World Tour 2026 Conference started with the opening remarks by Dr. Andreas Lewke, Managing Director (Thailand) Dr. Eckel Animal Nutrition. Dr Andreas Lewke has more than two decades of experience in Asia and a strong focus on sustainable, innovative animal nutrition. Dr. Eckel Animal Nutrition from their Bangkok office, the team has worked closely with integrators, feed mills and farmers across Asia and their main interest is how innovative, sustainable nutrition concepts can support both healthy animals and healthy profits. Dr. Andreas Lewke said today

Dr. Eckel Animal Nutrition is one of the international specialists for phytogenic solutions based on plant-derived active ingredients and their products are used in poultry, swine, ruminant and aquaculture nutrition around the world. The aim is always the same: to help the customers achieve direct and long-term success with healthy growth, high-quality products and efficient, resource-friendly production.

Dr. Viktor Eckel, Managing Director, Dr. Eckel Animal Nutrition in his keynote address highlighted “Plants Paving the Way for Future Animal Nutrition.

From the very beginning Dr. Eckel Animal Nutrition has focused on innovative feed additives that combine animal health, performance and sustainability. Dr. Viktor Eckel continues to shape the future of plant-based solutions and next-generation feed additives for animal nutrition. countries on almost all continents. He said the company’s products are manufactured in Germany to the highest quality standards. More than 75% of the raw materials requirement are sourced from European Union countries thus ensuring shorter supply routes and flexible manufacturing processes. Experts associated with the company from more than 20 countries are working towards ensuring the company’s growth.

After Coffee Braek, Dr. Anne Möddel, Team Lead Technical Sales, Dr. Eckel Animal Nutrition gave presentation on “Choosing the Right Phytogenic Solution to Achieve Your Goals”. At Dr. Eckel, Dr. Anne Möddel serves as a key technical contact for sales teams, partners and customers, providing in-depth expertise on phytogenics and monogastric nutrition. Her nice presentation was followed by Lunch.

Post Lunch, Dr. Nancy Salamanca, DVM, Ph.D., Independent Consultant & Professional Lecturer gave presentation on “Making Antibiotic-Free Farming Work: A Nutritionist’s Perspective”. Dr. Nancy Salamanca highlighted the importance of targeted feed solutions, gut health management, and practical nutritional approaches that help producers maintain animal performance while reducing reliance on antibiotics.

Dr. Le Van Phan, DVM, PhD, Assoc. Professor, Department of Microbiology and Infectious Disease, College of Veterinary Medicine, Head. Laboratory of Viral Infectious Diseases, Center for Research Excellence and Innovation, Vietnam National University of Agriculture gave update on ASF outbreaks in Vietnam (2019–2025) – Insights and Lessons Learned. It was privilege to hear the insights and research contributions of eminent Speakers.

Dr. Bernhard Eckel, Vice President, Dr. Eckel Animal Nutrition spoke on “Closing Reflections & Future Outlook”. Dr. Bernhard said their company has a motto – act local and think global. Dr. Eckel Animal Nutrition establishes sustainable social and ecological conditions across its product value chains as its products are sold globally and have wide footprints. By embracing such innovations, Dr Eckel protects the livestock but also contributes to a healthier, more efficient, and eco-friendly agricultural future for the world. The company participates in all the global livestock and poultry events for expanding outreach of its unique products.

Events like this truly highlight the value of global collaboration, knowledge sharing and industry connections. It was nice opportunity for me to learn, connect and exchange practical knowledge with professionals from many countries. Thanks to Dr. Eckel Team and the speakers for creating such an important global platform for knowledge sharing.

Launch of Advanced Mycotoxin Management Solutions – Antox Plus & Antox Precise
Nanovet Nutrition Pvt. Ltd., a fast-growing and innovation-driven animal nutrition company in India, proudly announces its strategic collaboration with nu.ance Biotechnology, Switzerland, a global leader in science-backed mycotoxins management solutions. This partnership marks a significant milestone in Nanovet’s journey to bring globally validated, high-performance nutritional technologies to the Indian poultry industry.

As part of this collaboration, Nanovet Nutrition has introduced two advanced toxin-management solutions to the Indian market—Antox Plus and Antox Precise.

Antox Plus offers comprehensive protection by targeting Mycotoxins, Endotoxins, and Chemical toxins, addressing the broader spectrum of feed-borne challenges.

Antox Precise is a highly selective solution dedicated exclusively to mycotoxin management, ensuring precise binding without compromising essential nutrients.

Together, these innovations strengthen feed safety, support animal health and performance, and enhance profitability for farmers and integrators.

Successful Multi-City Launch Events Across India
To mark the official launch of Antox Plus and Antox Precise, Nanovet Nutrition successfully conducted a series of launch events across three strategic poultry hubs in North India. These events witnessed enthusiastic participation from poultry farmers, integrators, veterinarians, consultants, distributors, and industry professionals.
Launch Event Details
· 15th December – Karnal
Venue: Vivaan Hotel, Karnal
· 17th December – Pathankot
Venue: Zone by The Park, Pathankot
· 19th December – Lucknow
Venue: Holiday Inn, Lucknow

Each event served as a dedicated knowledge-sharing platform focusing on Mycotoxin, Endotoxin and Chemical toxin risk management, field challenges, and innovative nutritional interventions aligned with Indian feeding practices.

Strong Technical Leadership & Global Expertise
The launch programs were successfully conducted by the Nanovet Nutrition team, led by experienced technical and commercial professionals who shared valuable insights on Toxins prevalence, impact on poultry performance, and the scientific advantages of Antox Plus and Antox Precise.

Nanovet Nutrition Team
· Dr. Deepak Singh – Technical Director
· Dr. Karthiga Kesavan– Product Manager
· Deepak Solanki- Regional Sales Manager-North
· Dr. Anirudh Ahlawat- Technical Service Manager- North
· Dedicated regional sales team members

nu.ance Biotechnology Team
· Dr. David Harrington – Chief Product Officer
· Mr. J. S. Uppal – Business Director, South Asia
Their presence reinforced the strength of the collaboration and highlighted nu.ance’s commitment to supporting Indian poultry producers with proven, research-driven solutions.

Antox Plus & Antox Precise – Science That Delivers Results
Antox Plus and Antox Precise are formulated using advanced adsorption and biotransformation technologies, developed through extensive global research and validated under diverse field conditions.

Key benefits include:
· Broad-spectrum Mycotoxins, Endotoxins and Chemical Toxins binder.
· Improved gut health and nutrient utilization.
· Enhanced flock performance and consistency.
· Reduced economic losses linked to mycotoxins.
These products are specifically adapted to Indian raw material variability, making them reliable solutions for modern poultry challenges.

Strengthening Nanovet’s Commitment to the Indian Poultry Industry
The successful execution of the multi-city launch events reflects Nanovet Nutrition’s strong field connect, technical capability, and commitment to delivering value-driven solutions. The collaboration with nu.ance Biotechnology further strengthens Nanovet’s product portfolio and reinforces its position as a trusted partner for poultry producers across India.

Nanovet Nutrition continues to focus on innovation, quality, and farmer-centric solutions, bridging global science with local expertise to support sustainable and profitable animal production.

Nanovet Nutrition Pvt. Ltd. – Turning Ideas into Innovations.

Nanovet Nutrition Private Limited, a fast-growing, science-driven animal health and nutrition company, announced a strategic collaboration with nu.ance Biotechnology, Switzerland, during Poultry India. This partnership marks a significant milestone in Nanovet’s journey to strengthen its global scientific footprint and deliver advanced, research-backed solutions to the Indian livestock industry.

About Nanovet Nutrition Pvt. Ltd.
Nanovet Nutrition Private Limited is committed to enhancing livestock productivity, animal welfare, and farm profitability through innovative, technology-driven nutritional solutions. The company has established strong expertise in veterinary nutraceuticals, gut health enhancers, feed quality solutions, and biosecurity technologies, addressing the evolving needs of the poultry, ruminant, swine, and companion animal sectors.

Headquartered in Bengaluru, India, Nanovet integrates research, innovation, sustainability, and customer-centric development to deliver measurable performance outcomes for producers. Through continuous investment in science and strategic global collaborations, Nanovet is rapidly emerging as a progressive and reliable partner in animal nutrition and health. Under the visionary leadership of Mr. Sanjeev Khanna, Managing Director, Nanovet Nutrition has witnessed accelerated growth and industry recognition. With deep domain expertise and a strong focus on innovation, Mr. Khanna has steered the company toward adopting advanced technologies, strengthening scientific alliances, and building long-term value for customers and stakeholders. His leadership continues to position Nanovet as a future-ready organization aligned with global best practices.

Strategic Collaboration with nu.ance Biotechnology, Switzerland


As part of its commitment to bringing world-class science to India, Nanovet has entered into a strategic collaboration with nu.ance Biotechnology, a Switzerland-based biotechnology innovator renowned for its advanced nutritional technologies and mycotoxin management solutions.

nu.ance Biotechnology brings strong global credentials, including:
– A state-of-the-art production facility in France
– Commercial presence across 40+ countries
– Specialized expertise in postbiotics, globa.biotics, feed additives, and next-generation nutritional technologies.

This collaboration significantly enhances Nanovet’s technical capabilities and supports the introduction of high-performance, research-validated feed solutions tailored to the needs of Indian and neighboring markets.

Leadership Presence at the Collaboration Event
The collaboration was formally reinforced during a dedicated event at Poultry India, attended by senior leadership from both organizations. The Nanovet delegation was led by:
– Mr. Sanjeev Khanna, Managing Director
– Dr. Deepak Singh, Technical Director
– Mr. Avinash Kharat, National Sales Head
– Along with members of the commercial and technical teams.

nu.ance Biotechnology was represented by:
– Dr. David Harrington, Chief Product Officer
– Mr. J. S. Uppal, Business Director – South Asia.
The presence of senior leadership underscored the shared commitment of both companies toward innovation, knowledge exchange, and long-term market development.

Nanovet × nu.ance: A Future-Focused Partnership
Through this collaboration, Nanovet Nutrition aims to leverage nu.ance Biotechnology’s global expertise in biotechnology, formulation science, and quality systems to further enhance product performance and deliver superior value to customers. Together, both organizations are aligned in their vision to introduce globally benchmarked, sustainable, and performance-oriented innovations for the livestock industry.

This strategic alliance reinforces Nanovet Nutrition’s position as a science-led, globally connected partner, dedicated to shaping the future of animal nutrition in India and beyond.

During my interaction with Dr. Andreas Lewke, Managing Director (Thailand) at Dr. Eckel Animal Nutrition, Germany, I gained valuable insights into how phytogenic feed additives and sustainable nutrition strategies are shaping the future of poultry production and why India remains a key growth market for science-based nutrition solutions. With over two decades of experience across Asia, Dr. Lewke has worked closely with poultry integrators, feed mills and nutritionists to improve gut health, feed efficiency, bird robustness and profitability through plant-derived active ingredients. Our discussion highlighted how these phytogenic solutions can help Indian poultry producers address challenges such as feed cost volatility, disease pressure, heat stress and reduced antibiotic use, while delivering measurable long-term value.

Ricky Thaper: For our readers in India, could you briefly introduce Dr. Eckel Animal Nutrition?
Dr. Andreas Lewke: Dr. Eckel Animal Nutrition is a family-owned company from Germany, founded more than 30 years ago. From the very beginning we have focused on innovative feed additives that combine animal health, performance and sustainability. Today we are one of the international specialists for phytogenic solutions based on plant-derived active ingredients. Our products are used in poultry, swine, ruminant and aquaculture nutrition around the world. The aim is always the same: to help our customers achieve direct and long-term success with healthy growth, high-quality products and efficient, resource-friendly production.

” Phytogenic nutrition isn’t a concept for tomorrow—it’s delivering performance, health and profitability in poultry production today.”

– Dr Andreas Lewke

Ricky Thaper: What makes Dr. Eckel’s solutions particularly relevant for poultry producers in a market like India?
Dr. Andreas Lewke: In many markets, advanced feed additives are sometimes still seen as “nice to have” products. Our experience in Asia shows that, under today’s competitive conditions, they are much more than that: in fact, they are important tools for securing performance and profit.

Our phytogenic products support gut health, feed efficiency and overall robustness of the birds, whether by helping them cope with stress, pathogen pressure or by diminishing the burden of endotoxins. Together, these concepts help producers to get more value from every kilogram of feed, to stabilise performance under challenging conditions and to protect product quality, while supporting strategies to reduce the reliance on antibiotics and to respond to customer expectations for safe, high-quality poultry meat and eggs. We know that Indian poultry professionals already run very sophisticated operations. Our goal is to offer solutions that fit into these systems and add measurable value where it matters most.

Ricky Thaper: Could you tell us a bit about your own role and background?
Dr. Andreas Lewke: I am Managing Director of Dr. Eckel Animal Nutrition in Thailand and responsible for our activities in Asia. I have been working in the region for more than 20 years, always in the field of animal nutrition and feed additives. Over the years I have worked closely with integrators, feed mills and farmers across Asia. My main interest is how innovative, sustainable nutrition concepts can support both healthy animals and healthy profits.

Ricky Thaper: How do you see your connection to the Indian poultry sector in particular?
Dr. Andreas Lewke: India is a key part of our Asian focus. The scale, professionalism and speed of development in the Indian poultry industry are impressive. Over the years I have had many discussions with Indian colleagues at conferences and during customer visits in the region.

What I see is a very strong base of local expertise and entrepreneurial spirit. Indian poultry professionals are highly knowledgeable and very open to new ideas, but they rightly expect clear evidence and practical benefits. They ask tough, practical questions: does it work in my conditions, is it economic, does it help me secure my business in the long run? This mindset fits very well with how we work at Dr. Eckel.

Ricky Thaper: From your perspective, how would you describe the Indian poultry industry today – its strengths and its main challenges?
Dr. Andreas Lewke: India is already one of the largest poultry producers in the world and still has significant growth potential. Rising incomes, urbanisation and changing food habits are driving demand for affordable, high-quality animal protein. Poultry is often the first choice because it is accessible, versatile and fits well with consumer preferences.

At the same time, the industry needs to manage several challenges. Feed raw materials can be expensive and volatile, so producers need to get the maximum value from every ration. Disease pressure and biosecurity are constant topics, especially in high-density production areas.
There is also a clear move towards reducing antibiotic use and towards more sustainable, welfare-orientated production systems that make better use of resources. For us, this combination of strong market growth and pressure on costs and resources makes India not only one of the most important poultry markets globally but also one of the most inspiring to work with.

Ricky Thaper: In this context, how do you see Dr. Eckel contributing to Indian poultry in the coming years?
Dr. Andreas Lewke: We see our role as a trusted partner. Our task is to contribute proven tools and know-how that support the goals Indian companies have set for themselves. In practical terms, this means working to implement phytogenic concepts that fit Indian conditions. Our products support better gut health, more stable performance and consistent meat and egg quality, even under heat or pathogen stress and other challenges.

With our experience in the phytogenic sector, our solutions that unite profit, health and quality, our innovative portfolio and our flexible, customer-orientated service, we believe we can make a meaningful contribution to the continued success of the Indian poultry sector.

Ricky Thaper: Finally, what message would you like to share with Indian poultry professionals who are reading or watching this interview?
Dr. Andreas Lewke: First of all, I have great respect for what the Indian poultry industry has achieved. Indian poultry industry has built a strong, dynamic sector that keeps moving forward despite many external challenges. My message would be : “We at Dr. Eckel are keen to learn from Indian poultry industry leaders experience and to share our own expertise where it can help. If Indian poultry industry is interested in practical, sustainable nutrition concepts that support healthy growth, product quality and long-term success, we would be very happy to exchange ideas and explore how we can work together.”

-Ricky Thaper (www.rickythaper.com)

39th edition of SPACE 2025 organised from September 16 to 18, 2025 at the Rennes Exhibition Centre, in Rennes, western France, a leading livestock-producing region in Europe was a grand success. SPACE Exhibition is a premier platform for professionals across the poultry, dairy, swine and aquaculture sectors to explore and discuss advancements in animal farming. SPACE 2025 Exhibition featured over 1230 exhibitors from 40 countries and 1,02,000, visitors from 125 countries showcasing innovations across 11 sector-specific halls and a 16-hectare outdoor exhibition area. Mr. Didier Lucas, the new President of SPACE, highlighted the show’s role as a bridge between innovation and the future of sustainable livestock. Ms. Ane Marie Quemener, General Commissioner of SPACE, emphasized the exhibition’s mission to address global challenges in animal farming while strengthening international collaboration. Ms. QUEMENER, added that the efforts and hard work by SPACE Team has given excellent results.

At NU.ANCE Biotechnology booth, I had good meeting with Dr. Nemanja Todorovic, Chief Business officer, NU.ANCE Biotechnology is specialised in development and commercialisation of innovative feed additive products, merging expertise in technical and scientific knowledge. Mr. Joginder Singh, Uppal, Business Director, is very efficiently heading the NU.ANCE Biotechnology business in India and other South Asian Countries.

During SPACE Exhibition, it was nice to meet and interact with Dr. Bernhard Eckel, Vice President–Sales, Dr. Eckel Animal Nutrition GmbH & Co. KG, based in Niederzissen, Germany. Over the past three decades, Dr. Eckel has grown from a family business into a globally recognized provider of alternative feeding solutions and has become one of the global leaders in sustainable animal nutrition.

Ms. Cecile Berthier, International Press and Exhibitors Information, highlighted the importance of giving visibility to such innovations, enabling exhibitors to gain recognition and enhance global reach. Poultry and Dairy Farms visits were also arranged for the international visitors. SPACE 2025 is fostering innovation, collaboration and growth within the global livestock and poultry sectors.

At Biochem booth I had good interaction with Mr. Niels Otto Damholdt, Sales Director, Biochem. The Company headquarter is located in the northwest German town of Lohne, supplying high quality feed additives for poultry and livestock. Dr. Bhaskar Choudhry is heading the Biochem business in India which has good growth in terms of volumes and sales.

It was nice to meet Mr. Xavier Cadiou, CEO of Agri Reseaux International and VIV worldwide partner for France at his booth during SPACE 2025. Mr. Cadiou updated that he is working on the participation of French companies at VIV Select India 2026 being organised at Yashobhoomi, New Delhi, from April 22-24, 2026.

Amandine Leroux, International Development, SPACE, reiterated the importance of building meaningful international partnerships through knowledge-sharing and collaborative discussions.

The International Club being supported by Bretagne Commerce International, Business France, and BPI France, has provided a dedicated space for international visitors and exhibitors to do networking, conduct business meetings and explore partnership opportunities.

Tailored farm visits also being organized for international delegates said Ms. Chloe Letellier, Communication Press, SPACE. During SPACE 2025, I attended conference and symposia on poultry and livestock, covering topics such as environmental assessment in poultry farming, dairy farming, aquaculture and the application of artificial intelligence in livestock and agriculture. These sessions provided actionable insights and practical solutions tailored to the evolving needs of the agricultural sector.

At Aviagen booth, I met Mr. Florian Blevin, International Commercial Manager SSA, Aviagen Limited and had good interaction.

At Novogen booth, I had good interaction with Mr. Stephane Lemoine, Director, Business Development, Novogen along with Mr. Vaibhav Aghi, Director, Aghi Group, Dr. SK Bhardwaj and other delegates from India. AGHI Group’s Easy Poultry Innovation LLP has partnered with global poultry genetics leader Novogen to introduce the Novogen layer breed in India from 2026, marking a significant milestone for the country’s poultry sector. Mr. Vaibhav said their collaboration with Novogen aims to provide Indian farmers with a high-performing layer bird known for excellent laying persistency, uniform egg quality, and efficient feed conversion. Combining Novogen’s global expertise with AGHI Group’s local network and farmer-focused approach, the partnership seeks to drive sustainable, profitable, and high-quality egg production in India.

One of the International visitor visiting the show, said “As a key platform for international trade, SPACE emphasizes energy conservation, bio-security, and veterinary advancements, making it indispensable for professionals from Poultry and Dairy Industry, globally. It’s truly the “Livestock Planet.” Another International visitor said great success at SPACE Exhibition! Inspiring innovations, valuable connections, and unforgettable experiences. Glad to know that SPACE Exhibition exceeded expectations! Thanks to organizers, exhibitors, and visitors especially a large content of Indian visitors for making it happen. While interacting with exhibitors, they rated SPACE as very high quality trade show. In the evening attended the Reception organised by SPACE for the Press and their VIP delegates which was addressed senior officials of SPACE Team.

The next edition of SPACE is scheduled for September 15–17, 2026, at the Rennes Exhibition Centre, Rennes, France.

Dr. Stéphanie Ladirat, R&D Director, NUQO

A recent research program highlights that micro-encapsulation of seaweed and plant extracts can stimulate digestive functions, improve performance, and reduce feed costs, addressing current egg industry needs.

The egg industry grapples with key challenges in optimizing nutrition and profitability for laying hens. One significant hurdle involves efficiently producing eggs while maintaining bird health and well-being. Sustainable practices, such as efficient waste management and reducing the environmental footprint, are essential to address growing concerns about the environmental impact of egg production. To tackle these issues and enhance the performance of laying hens, strategies have emerged. These include formulating balanced diets with alternative protein and energy sources, exploring feed additives like enzymes, microbials, phytogenics, and seaweed extracts. Enzymes, such as phytase, improve nutrient utilization, while probiotics and prebiotics support gut health, enhancing feed conversion and disease resistance. Natural phytogenics provide antioxidants, affect the microflora profile, and improve digestive functions, ultimately leading to increased egg production and improved egg quality. Seaweed bioactives (so called-phycogenics), contribute as well to better gut health of animals. These strategies address challenges in egg production and meet consumer expectations for high-quality, nutritious eggs, all while promoting sustainable and eco-friendly practices.

The latest benchmark for phytogenic feed additives
Lately, a feed additives company has introduced an innovative product, NUQO©NEX (NQ), comprising metabolites sourced from both plants and algae (referred to as phytogenic and phycogenic, originating from the Greek words ‘phytos’ for plant and ‘phycos’ for algae). These metabolites are shielded by a unique micro-encapsulation technology. The utilization of micro-encapsulation has become imperative in the realm of phytogenic feed additives to mitigate the volatility of natural compounds. While the term ‘encapsulation’ is increasingly generic, it is crucial to discern authentic technology that not only safeguards but also effectively releases active ingredients, setting it apart from rudimentary methods like silica absorption or light-agglomeration, which may suffice for various compounds but fall short in preserving delicate phytogenics like essential oils.

It is of utmost importance to delve into the manufacturing technology underpinning each product, rather than solely relying on surface-level claims. With its notably high concentration of active components and remarkable stability, this novel solution assures a precise release in the digestive tract and offers a cost-effective dosage unlike any other currently available. This technology has been meticulously developed to optimize poultry performance and can serve as an alternative growth promoter or a means to enhance feed conversion ratios and overall performance, ultimately resulting in an improved return on investment for poultry operations.

Numerous trials have validated the effectiveness of this technology in enhancing the performance of laying hens across diverse contexts and geographic regions. Concurrently, scientists have conducted assessments to gauge the technology’s precise influence on feed digestibility. This research aims to provide formulators and nutritionists with greater flexibility in their decision-making processes.

Enhancing Feed Digestibility in poultry
In a recent study conducted at the University of Berlin in Germany, researchers undertook a comparative analysis of four treatments: a negative control, two commercial products incorporating phytogenics (referred to as P1 & P2), and a novel technology, NUQO©NEX (NQ). The findings revealed that the NQ treatment not only enhanced the digestibility of nutrients like crude fat, crude protein, and starch but also contributed to increased mineral digestibility, including crude ash, calcium, and phosphorus, when compared to the negative control. The other two solutions also improved the digestibility of certain nutrients and minerals but to a lesser extent than NQ. Notably, the NQ treatment exhibited the most pronounced effects on nutrient and mineral digestibility, resulting in the highest overall performance improvement. In sum, the NQ treatment demonstrated enhanced feed digestibility, ultimately leading to improved performance, in contrast to conventional products relying on phytogenics. This underlines the significance of the formulation’s composition (comprising both phytogenics and phycogenics) and the influence of manufacturing technology (micro-encapsulation) on product stability and release within the digestive system.

Concrete impact on feed costs with a conservative matrix value
The NQ technology underwent extensive testing in various global regions, including Asia, Europe, and Latin America, to evaluate its impact on the performance of laying hens. Additionally, to offer maximum flexibility to nutritionists and formulators, diverse scenarios were examined, involving the application of feed additives either “on top” of the formulation or using a “matrix value” approach, allowing adjustments to the feed formulation to reduce costs by decreasing energy and protein content. Two recent trials were conducted at Kasetsart University in Thailand under the guidance of Professor Yuwares.

In an experiment, the NQ technology was used with a “matrix value” at 75 ppm. Three treatments were tested: 1) an initial control diet [C0], 2) a second treatment that consisted of the same control diet but with reduced energy and protein content (-23 kcal/-0.25% dig.Prot) [NC], and finally, 3) a third treatment was given to animals based on the control diet, with reduced energy and protein content (-23 kcal/-0.25% dig.Prot) along with the NQ technology at 75 ppm [NC+NQ]. In this case as well, the experiment consistently delivered expected results. Applying a matrix to the control diet (NC) adversely affected laying percentage, egg mass, and FCR but did not alter feed intake when compared to the control. Applying NQ technology with a matrix value (NC+NEX) helped to restore layer performance, with the laying percentage even slightly surpassing that of CO.

Beyond performance indicators, additional assessments highlighted the influence of the NQ technology. Researchers observed a decrease in both fatty liver scores and occurrences. Moreover, there was an enhancement in eggshell thickness, whether the technology was used in a diet, with or without a matrix value.

Opt for the latest, science-backed technology to safeguard profits
In the evolving landscape of the egg industry, the NQ technology emerges as a revolutionary solution. By seamlessly combining exclusive ingredients sourced from both plants and algae, it offers a distinctive advantage. What sets this technology apart is its genuine micro-encapsulation method, ensuring the safe and efficient release of active components. Through extensive trials, the remarkable effects on laying hens’ performance, improved feed digestibility, enhanced egg quality, and notable reduction in costs have been demonstrated. NQ technology is not just one more phytogenic feed additive, but rather the most advanced nature-based technology for optimizing laying hens’ performance at competitive cost. It serves as a cornerstone for the future of egg production, delivering unparalleled advantages to producers and championing healthier, more sustainable laying hens’ operations.

Dr. Natthanan Nukitrangsan,
Ph.D, Feed Nutritionist & Technical Consultant
CP BIO

Introduction
Imbalances in the intestinal microbiota are linked to the development of various diseases. As a result, there has been growing interest in using prebiotics, probiotics, and postbiotics to modulate the gut microbiome. Postbiotics refer to substances released or produced through the metabolic activity of microorganisms that exert beneficial effects on the host, either directly or indirectly. Since postbiotics do not contain live microorganisms, the risks typically associated with their consumption are significantly reduced.

In this review, we critically examine current literature on postbiotics, focusing on their mechanisms of action and potential applications in performance trials. We highlight their distinct benefits compared to live probiotics, with the goal of maximizing the effectiveness of postbiotics in target animals. The review explores their key components and advantages related to diet and gut health, emphasizing their role in supporting animal production—particularly in poultry. Relevant studies are referenced to illustrate the immunomodulatory, antimicrobial, anti-inflammatory, and antioxidant properties of postbiotics, as well as their overall impact on productivity and health in animal systems.

How to distinguish postbiotics and their benefits compared to live probiotics?

Postbiotics are metabolic by-products produced by bacteria (exogenous postbiotics). They include non-viable bacterial components and substances such as short-chain fatty acids (SCFAs), peptides, bacteriocins, proteins, and amino acids, all of which can confer health benefits to the host. Unlike probiotics, postbiotics are more stable during feed processing and under various environmental conditions. This enhanced stability, along with their enriched nutrient profile, makes postbiotics a promising alternative to probiotics in animal feed applications.

The use of postbiotics as a tool for improving the health of livestock and poultry shows great promise, owing to their numerous benefits and several advantages over probiotics and prebiotics. As metabolic byproducts or components derived from probiotic bacteria, postbiotics are less sensitive to environmental factors such as temperature, pH, and processing methods (Hossain et al., 2021). This enhanced stability allows them to retain their functional and beneficial properties over time, making them well-suited for diverse applications in animal health and nutrition (Thorakkattu et al., 2022).

Furthermore, we provided the information of postbiotics that can offer more advantages than live probiotics; for instance, (Rafique et al., 2023),

(a) Live probiotics may struggle to adhere to the gut mucosa due to the presence of a mucous layer that limits direct contact between bacteria and the epithelial surface. In contrast, postbiotics can more easily penetrate this mucous layer.
(b) Postbiotics pose no risk of infection from bacterial translocation from the intestinal lumen into the bloodstream, which is particularly important for immunocompromised or susceptible individuals. Additionally, they do not carry the risk of acquiring or transferring antibiotic resistance genes.
(c) Postbiotics offer practical advantages—they are easier to dose, transport, standardize, and store. Moreover, they have significant potential to support intestinal barrier function and may serve as an effective alternative to probiotics (Liu et al., 2023).

The benefits of postbiotics for gut health.
Postbiotics can inhibit the growth of pathogens and strengthen gut barrier function through the action of short-chain fatty acids (SCFAs). For instance, butyrate serves as an energy source for colon epithelial cells and the intestinal mucosa, thereby supporting gut integrity and reducing intestinal permeability.
In addition to enhancing gut barrier function, butyrate plays a role in immunomodulation and exhibits anti-inflammatory effects while helping to improve growth performance, as illustrated in Figure 1.

Figure 1: Functions of postbiotics

Butyric acid has demonstrated in vitro antimicrobial activity against both Gram-positive bacteria (e.g., Enterococcus faecalis, Clostridium perfringens, Streptococcus pneumoniae, Streptococcus suis) and Gram-negative bacteria (e.g., Escherichia coli, Salmonella enterica Typhimurium, Campylobacter jejuni) (Kovenda et al., 2019).

The mode of action of sodium butyrate involves its conversion to butyric acid, which can penetrate bacterial cell walls primarily through diffusion. Once inside the cell, butyrate induces cytoplasmic toxicity by lowering the intracellular pH. This acidification disrupts key metabolic processes, depletes energy reserves, and leads to the excretion of protons (H⁺), which further diffuse into the bacterial cell and contribute to toxicity. The increased proton concentration interferes with ATP synthesis by impairing the bacterial cell’s ability to maintain proton gradients essential for energy production and metabolism. Ultimately, the drop in pH and metabolic disruption result in bacterial cell death (Ahsan et al.,2016).

Maximize the effectiveness of postbiotics in target animals.
Based on researches, postbiotic can be able to target gut-brain axis influence on serotonin to improve growth performance (Sofie et al., 2021; Ishii et al.,2019), gut health and nutrient digestion (Ahmed et al., 2014; Kumar et al., 2014), antimicrobial (Mantziari et al., 2020; Fong et al., 2020), anti-inflammation and Immune-microflora balance (Torino et al., 2015; Miyazawa et al., 2015; Maghsood et al., 2018;) including postbiotic/probiotic as an alternative ATB/ZnO (Ali et al., 2023).

FermNutral® derived from the biological fermentation of the probiotic strain Clostridium butyricum, the main components of the product include amino acids, minerals, and beneficial metabolites classified as postbiotics. Rafique et al. (2023), writing in the Journal of Agriculture & Food Research, reviewed the principal classes of postbiotics with health-promoting effects:

1. Short-chain fatty acids (SCFAs) –
Butyrate supports gut integrity, reduces intestinal permeability, modulates immunity, exerts anti-inflammatory actions, and suppresses pathogens. In broilers, butyrate also raises apparent total‑tract crude‑fat digestibility and apparent metabolizable energy (AME), enhancing overall digestion and nutrient absorption.
2. Antimicrobial peptides (bacteriocins) – These peptides display activity against common pathogens, including Salmonella spp., Staphylococcus aureus, Yersinia enterocolitica, and Escherichia coli.
3. Quorum‑sensing (QS) interference – Certain postbiotics inhibit pathogen biofilm formation by disrupting QS signaling, thereby curbing colonization and persistence.
4. Polysaccharides (e.g., teichoic acids) – Contribute anti‑ inflammatory and antimicrobial effects, further supporting host health.
5. B‑complex vitamins, proteins, and amino acids – Provide additional nutritional and functional benefits that complement the antimicrobial and immunomodulatory actions of other postbiotic fractions.

Postbiotic product in poultry trials
FermNutral (FN)® is a postbiotic product consisting of non-living microorganisms (inactivated bacteria) or their components that provide health benefits to the host. It also includes byproducts of probiotic activity in the gut, such as fermentation metabolites.

The main ingredient is calcium butyrate, which makes up 50% of the product. Other components include short-chain fatty acids (butyric acid, acetic acid, propionic acid), 18 amino acids, vitamins (B1, B2, B5, B6, B12, folic acid, E, and K), and minerals (Ca, Fe, Zn, Na, Mg, P, Mn, Cr).

Based on our trial data and correlated research publications, we can confidently say that FN improves productive performance and reduces feed costs, which contributes to higher profits and effective solutions in animal production.

Typically, we focus on both performance and economic returns in animal production, especially for pigs, poultry, and aquatic species. Through extensive research conducted by CP BIO, we have found that using FN in aquatic animals such as Tilapia, Ruby fish, Penaeus vannamei, and Micropterus salmoides significantly enhances growth performance, feed efficiency, survival rates, and overall economic returns, as shown in Table 1.

Conclusions
FermNutral (FN) is a biological fermentation product derived from the probiotic strain Clostridium butyricum. It primarily contains short-chain fatty acids (SCFAs), especially butyrate, along with amino acids, minerals, and beneficial metabolites acting as postbiotics. Essentially, FN functions through the diet-gut-microbe axis to provide effective animal health solutions. Butyrate mainly supplies energy to the epithelial cells of the colon, improving digestion and nutrient absorption while controlling pathogens, maintaining immune balance, and reducing inflammation. Therefore, the multi-modal actions of FN help support gut function, enhancing animal performance and profitability.

References available on request.

Indian Animal Health Industry
The veterinary healthcare sector in India is experiencing significant growth, with the market size estimated to be USD 1.25 billion in 2024, projected to reach USD 1.89 billion by 2029, indicating a robust CAGR of 8.63% during the forecast period. This growth is particularly notable in the poultry industry, which has emerged as one of the fastest-growing sectors among livestock species. The poultry sector has evolved into a key supplier of affordable protein sources, driving the development of value chains that cater to consumer demand.

Stallen South Asia: Leading by Change and Setting a Standard
In response to this market dynamic, Stallen South Asia Private Limited has emerged as a key player, offering indigenous solutions and expertise in animal health. By bridging the gap between global standards and local requirements, companies like Stallen are not only contributing to the growth of the poultry industry but also fostering a resilient and sustainable ecosystem for animal health management in the country.

Stallen stands out as a leading name in India’s animal health sector, offering a diverse range of products tailored for poultry and cattle across four distinct divisions. These divisions encompass feed additives, biosecurity solutions, formulations, and vaccines, showcasing Stallen’s comprehensive approach to animal health management.

Strategic Collaborations and Industry Partnerships – 25 Years in the Marking
The company’s journey traces back to its inception in 1997. Since inception, Stallen has constantly developed to stay in line with the industry standard – in 2010 Stallen entered a JV with FATRO from Bologna, Italy. This JV enabled Stallen to import and distribute a wide range of killed and live vaccines, further solidifying its position in the market.

Global Reach and Market Presence
Over the 25 years, Stallen has expanded its footprint and capacities. Today, Stallen’s export operations span more than 50 countries across 6 continents serving as a testament to our product quality and service.
In an attempt to completely self suffienct, Stallen has backward integrated and control the end-to-end supply chain. As a result, they currently operate 5 different manufacturing locations in addition to the 2 supply plants of FATRO:
1) Feed Additives Manufacturing Unit in Palghar, Maharashtra
2) Feed Additives Manufacturing Unit in Sajjanpada, Maharashtra
3) Feed Additives and Cattle Feed Premix Manufacturing Unit in Alexandria, Canada
4) Therapeutics/Formulations Manufacturing Unit in Nandore, Maharashtra
5) Halquinol API Manufacturing Unit in Vatva, Gujarat

Focus on Quality and Regulatory Compliance
All of Stallen’s plants are certified and regularly audited by ISO, GMP, and FDA, along with approvals from international regulatory bodies, attestesting to their adherence to rigorous standards in manufacturing and product safety.

1) Feed Additives and Premix Factories in Maharashtra
Stallen South Asia Pvt. Ltd., based in Nandore, Maharashtra, India, specializes in manufacturing a wide range of feed additives and supplements. Their product portfolio includes antibacterial solutions, treatments targeting mycoplasmal infections, deworming agents, performance enhancers, anthelmintics, mineral supplements, toxin-binding formulations, antidiarrheals, growth promoters, anticoccidials, water sanitation products, fly control solutions, and disinfectants. These products are meticulously crafted and made available in various convenient forms such as tablets, boluses, powders, oral liquid solutions.

1. Manufacturing Process: The factory has specialized equipment and facilities for the manufacturing process. This includes mixing and blending equipment for creating formulations, granulation machinery for solid products, liquid mixing and filling lines for liquids, and packaging lines for various forms of products.
2. Quality Assurance: Quality control measures are integral to the manufacturing process. Raw materials are tested for purity and quality before use. During production, in-process checks are conducted to ensure consistency and adherence to specifications. Finished products undergo rigorous quality testing for efficacy, safety, and compliance with regulatory standards.
3. Regulatory Compliance: The factory operates in compliance with regulatory requirements set by local and international regulatory bodies, with approvals from China, Iran, Australia and more. This includes adherence to Good Manufacturing Practices (GMP) and documentation of processes to ensure product quality and safety.

2) Formulation Unit in Palghar, Maharashtra, India.
It is a crucial facility for manufacturing pharmaceutical products that range between regular therapeutic drugs as well as beta-lactam formulations.
1. Facilities and Equipment: The formulation unit is equipped with state-of-the-art facilities and machinery required for the formulation and production of pharmaceutical products. This includes equipment for mixing, blending, granulation, drying, and packaging. The capacities are built for effervescent tablets, liquid form (oral and topical), oral powder, bolus and ointment.

2. Quality Control: Throughout the formulation process, rigorous quality control measures are implemented to ensure that the final product meets regulatory standards and specifications. This includes testing the raw materials, in-process samples, and the finished product for purity, potency, stability, and safety.

3. Regulatory Compliance: The formulation unit operates in compliance with regulatory requirements set by authorities such as the Food and Drug Administration (FDA) in India. This includes adherence to Good Manufacturing Practices (GMP), documentation of processes, and regular inspections to ensure quality and safety standards are maintained.

3) “Stallen Unveils Cutting-Edge API Facility for Halquinol Production!”
To maintain its commitment to quality, affordability, and timely delivery, Stallen has commenced the production of Halquinol, a non-antibiotic growth promoter classified under hydroxy-quinolines. This compound comprises 5-chloro-8-hydroxyquinoline, 5,7-Dichloro-8-hydroxyquinoline, and 7-Chloro-8-hydroxyquinoline, with the product Halquinol 98% manufactured in accordance with BP 80 (British Pharmacopeia 1980) specifications. Stallen offers Halquinol 98% as a chemical API for use in veterinary formulations and feed additives, alongside the commonly available 60% and 12% variants. With its adherence to BP specifications and increased monthly production capacity, Stallen is well-equipped to cater to global demand, holding valid registrations for Halquinol in over 15 countries.

Stallen’s strategic vision includes gradually introducing a range of APIs from its Vatva facility, aiming to reduce reliance on imported products from China in the animal health sector. The Vatva plant marks the fifth addition to Stallen’s manufacturing infrastructure, complementing its existing feed additive and veterinary formulation facilities in Palghar, Maharashtra, as well as a feed premix and additive manufacturing unit in Canada. This strategic expansion underscores Stallen’s commitment to self-sufficiency and quality assurance in delivering essential solutions for animal health and nutrition.

Mycotoxins in the food chain: Understanding risks and exploring mitigation strategies

By: Dr. Maloshrie Bora, Program Manager – Feed Safety, Trouw Nutrition South Asia

The safety of animal feed is increasingly compromised by a confluence of global challenges, notably mycotoxin contamination. These toxic metabolites, produced by molds such as Aspergillus and Fusarium, pose significant health risks to livestock and, by extension, to humans consuming animal products. Contributing factors include a shortage of quality raw materials, exacerbated by supply chain bottlenecks and geopolitical disruptions. Climate change further intensifies the issue by altering temperature and precipitation patterns, creating favorable conditions for mold growth and mycotoxin production. Additionally, inadequate storage and transportation facilities, often lacking proper ventilation and climate control, facilitate the proliferation of these harmful fungi. Together, these elements underscore the urgent need for comprehensive strategies to mitigate mycotoxin risks and ensure feed safety.

Even the smallest lapse in post-harvest handling can swiftly trigger the formation of harmful secondary metabolites like mycotoxins. Factors such as delayed drying, inadequate moisture control, and poor storage conditions can create an environment conducive to fungal growth, leading to rapid mycotoxin accumulation. For instance, aflatoxin contamination in maize has been linked to improper drying and storage practices, highlighting the critical importance of stringent post-harvest management to ensure food safety.

Mycotoxin contamination poses a significant threat to various stakeholders in the agricultural and food sectors, including farmers, feed producers, food processors, public authorities, and end consumers. These toxic compounds adversely affect animal health by impairing the gastrointestinal tract, suppressing the immune system, and disrupting nutrient absorption, leading to decreased productivity and increased susceptibility to diseases. Implementing a comprehensive 360-degree mitigation strategy—encompassing prevention, detection, regulation, and education—can effectively address this multifaceted issue and safeguard public health and economic interests.

The “Big 6” mycotoxins—aflatoxins, ochratoxins, fumonisins, zearalenone, deoxynivalenol (DON), and T2 toxin—are among the most prevalent and toxic secondary metabolites produced by molds affecting agricultural commodities. These toxins impact various species differently; for instance, aflatoxins primarily affect liver function in mammals, while zearalenone exhibits estrogenic effects leading to reproductive issues in ruminants and pigs.

The incidence and severity of mycotoxin contamination are influenced by environmental factors such as temperature, humidity, and rainfall, which can create conducive conditions for mold growth and toxin production. Not all mycotoxins are equally toxic across species; for example, DON is highly toxic to swine, whereas poultry are less affected. Climate change exacerbates the problem by altering weather patterns, potentially increasing the prevalence and distribution of mycotoxins in crops.

Aflatoxins occur worldwide in feed and feed stuffs which results in severe economic loss to poultry and livestock industries. The extent of Aflatoxin contamination varies with geographic location, farming methods and the susceptibility of commodities to fungal invasion during pre-harvest, storage, and processing periods. Numerous studies showed negative effects of Aflatoxin in broiler chickens including a decrease in the efficiency of feed utilization and body weight gain, liver damage, poor immune response, and increased mortality. Aflatoxin is shown to induce pathological alterations in important organs such as the liver, kidneys, and lymphoid organs. Furthermore, the transmission of aflatoxin B1(AFB1) and its metabolites from feed to animal edible tissues and products, such as the liver and eggs, becomes particularly important as a potential hazard for human health. Given the global economic importance of Aflatoxin, many strategies have been tried to minimize their negative impact. A successful prevention strategy must be economical and capable of eliminating all traces of toxin without leaving harmful residues and should not impair the nutritional quality of the commodities. Extensive research has been carried out using adsorbent (binder) materials that adsorbs to Aflatoxin molecule by means of ion exchange and thereby preventing their absorption into blood circulation. Among various binding agents, clays and yeast cell wall materials are the most tested. Silicates are the main group of clays that are studied extensively in terms of Aflatoxin binding. These include tectosilicates (zeolites), 1:1 phyllosilicates (kaolinite), 2:1 phyllosilicates (smectites, vermiculites, chlorites, micas) and sepiolite. All silicates, however, are not the same in terms of their ability to bind Aflatoxin and among the above, smectites have shown greater binding efficacy against Aflatoxin. The ability of smectite clays to bind mycotoxins depends on pH in the gut, molecular arrangements, and its geographic region of origin. Smectite clays possess high Aflatoxin adsorption capacity due to its high surface area, ion exchange capacity, and ability to swell in the presence of water, and the efficacy has been proven in vivo in broiler chickens. The leading hypothesis on the bonding mechanism between adsorbed aflatoxins and smectites is the electron donor–acceptor (EDA) model. Other models such as selective chemisorption, H-bonding, and bonding through furan rings were proposed.

The supplementation of smectite clay in feed to aflatoxin challenged broilers considerably reduced the magnitude of toxic effects of aflatoxin and improved growth and immune response. Hence, smectite clay could be successively used in feed to ameliorate the toxic effects of aflatoxins in broiler chickens.

Aflatoxin B1 (AFB1), deoxynivalenol (DON) and ochratoxin A (OTA) are ones of the most common and dangerous mycotoxins. AFB1, produced mainly by Aspergillus, is one of the most poisonous toxins, which is classified as Group I carcinogen by the World Health Organization due to its hepatoxicity, immunotoxicity, mutagenicity, genotoxicity, and carcinogenicity on variety of animals. DON, produced by many Fusarium molds, contamination in feeds induces anorexia, emesis, and damage to intestinal barrier and immune function in animals through suppressing the synthesis of nucleic and proteins . OTA, a toxic metabolite from Aspergillus and Penicillium molds, possesses hepatoxic, nephrotoxic, neurotoxic, immunotoxic, and teratogenic effects on liver and kidney. Long-term epidemiological investigations have shown that most of the global feed is exposed to more than one mycotoxin, and mycotoxin contamination of food and animal feed is a worldwide problem. Meanwhile, when three mycotoxins co-existed in the poultry feeds, their interaction have been further associated with significant alterations in the productivity and profitability of animals. Therefore, development of remediation strategies to prevent or mitigate the mycotoxicosis is imperative.

Trouw Nutrition’s TOXO® range offers a suite of mycotoxin binders designed to mitigate the negative effects of mycotoxin contamination in animal feed. These products are formulated to support animal health and performance by reducing the bioavailability of harmful mycotoxins.
These products are part of Trouw Nutrition’s comprehensive approach to mycotoxin risk management, aiming to ensure feed safety and optimize animal health and performance.

TOXO®-MX: Precision for Aflatoxins
TOXO®-MX is a specialized binder formulated to combat aflatoxins, particularly Aflatoxin B1, which can adversely affect dairy cows and other livestock. By incorporating purified smectite clays, TOXO®-MX effectively reduces the bioavailability of aflatoxins in the gastrointestinal tract. This reduction leads to a significant decrease in the excretion of Aflatoxin M1 in milk, ensuring compliance with regulatory standards and safeguarding consumer health. Additionally, TOXO®-MX enhances feed efficiency, as evidenced by improved milk production per kilogram of dry matter ingested in dairy cows.

TOXO®-XL: Comprehensive Protection Against Fusarium Mycotoxins
TOXO®-XL is an advanced binder designed to address the challenges posed by Fusarium-related mycotoxins, such as trichothecenes and fumonisins. This product combines smectite clays with specifically selected glucose biopolymers and purified β-glucans, which work synergistically to reinforce intestinal barrier function and modulate the immune response. The result is a comprehensive solution that not only binds and eliminates mycotoxins but also mitigates performance impairments caused by their exposure.

TOXO®: Broad-Spectrum Mycotoxin Binder
TOXO® serves as a versatile, broad-spectrum mycotoxin binder suitable for various animal species. It utilizes smectite clays to effectively reduce the bioavailability of a wide range of mycotoxins, including aflatoxins, ochratoxins, and zearalenone. By preventing the absorption of these toxins, TOXO® helps maintain animal health and performance, making it an essential component of comprehensive mycotoxin risk management strategies.
Collectively, the TOXO® product range represents a holistic approach to mycotoxin risk management, integrating advanced scientific formulations to protect animal health and ensure the safety of the food chain.

Sustainable Animal Health with Phytogenic Innovations: Dr. Eckel Leading the Way – Ricky Thaper (www.rickythaper.com)

One of the main challenges in modern animal farming is sustainably improving animal health and welfare. Animal health directly impacts food quality and animal productivity. Healthy birds/animals lead to better product quality, reduced treatment costs, more consistent yields, improved farm management and greater customer satisfaction.
In an era where climate change frequently affects animal productivity, natural resources are limited, and the global trade landscape continues to evolve, Dr. Eckel Animal Nutrition GmbH & Co. KG, based in Niederzissen, Germany, has taken a pioneering step toward supporting sustainable, resilient and successful livestock farming. During my recent visit to Germany, I had the opportunity to explore their state-of-the-art manufacturing facility, witnessing firsthand the innovation and commitment behind their global success.

Founded in 1994 by Dr. Antje Eckel, the company was established with a vision to make animal nutrition healthier, more welfare-oriented and sustainable. Over the past three decades, Dr. Eckel has grown from a family business into a globally recognized provider of alternative feeding solutions.

Dr. Antje Eckel has also served in various international roles promoting animal health. A key contributor to the company’s growth is Dr. Bernhard Eckel, Vice President – Sales, who has been associated with the company since its inception.

Further strengthening the leadership is Dr. Viktor Eckel, Managing Director – Products & Innovation, who combines his passion for life sciences and technology in product development. Also part of the team are Mr. Theo Eckel, Head of Purchasing and Ms. Klara Eckel, who leads business development initiatives serves as an authorised signatory.

The Importance of Gut Health
The animal gut is a complex ecosystem hosting diverse microorganisms that evolve with their hosts. Each section of the gut houses distinct microbial communities that shift throughout the animal’s life. In poultry, microbial colonisation begins at hatching and is influenced by the hen and the environment. Feed composition also plays a significant role in shaping the microbial profile and by extension, long-term health.
Managing gut health isn’t simply a battle between good and bad bacteria. Some microbes typically seen as harmful may play beneficial roles under specific conditions, while even beneficial ones can cause harm if imbalanced. A stable microbial balance is vital for maintaining animal health and performance. Gut health disturbances caused by poor feed quality or disease can severely impact productivity.

The long-standing use of antibiotic growth promoters (AGPs) comes with several risks. AGPs not only eliminate harmful bacteria but also beneficial ones, impairing digestion, increasing inflammation and weakening the immune system. Their prolonged use contributes to antibiotic resistance, prompting regulatory bans in many countries.

Phytogenics: A Natural Alternative
This growing concern has fuelled demand for natural, effective alternatives—among which phytogenics play a leading role. Derived from herbs, spices and plant extracts, phytogenic feed additives offer a selective, plant-based approach to enhancing gut health, boosting immunity and improving digestion.

Unlike AGPs, phytogenics target only harmful microbes while preserving the beneficial ones, ensuring a healthier intestinal environment. They also possess anti-inflammatory, antioxidant and immune-boosting properties, further supporting animal well-being.
With three decades of expertise in phytogenic feed additives, Dr. Eckel has become one of the global leaders in sustainable animal nutrition. The company focuses on identifying powerful plant-based compounds that can fully unleash nature’s potential to improve animal performance. Their additive solutions cover poultry, swine, ruminants, aquaculture and pets, with more than 10% of annual revenue invested in R&D.

Global Reach with Local Commitment
From its German headquarters, Dr. Eckel supplies products to Europe, CIS countries, and the Middle East. Through its Bangkok office, the company serves customers across Southeast and South Asia. With a skilled team of almost 80 professionals from over 20 countries, their solutions are now available in more than 40 countries worldwide.

Dr. Eckel’s products are manufactured to strict German quality standards, with over 75% of raw materials sourced from within the EU, ensuring short supply routes, flexible processes, and reduced environmental impact. This results in better animal welfare, high-quality products, and improved profitability for farmers. The company aligns its operations with FAO and UN Sustainable Development Goals and the EU’s climate targets under its guiding philosophy: Act local, think global.

Flagship Products Driving Innovation
Among Dr. Eckel’s top-performing innovations:
Anta®Phyt: A powerful phytogenic complex that enhances gut health and performance in poultry, swine, and ruminants. In a 42-day study with 1,155 broilers, Anta®Phyt increased beneficial bacteria like Lactobacillus and Bifidobacterium, while significantly reducing Escherichia coli. The result: better digestion, improved nutrient absorption, and enhanced growth—without antibiotics.

Anta®Ox Aqua: Designed for aquaculture, this product helps reduce Vibrio levels in shrimp farming. In a field trial with nine earthen ponds, shrimp treated with Anta®Ox Aqua showed a significant decrease in Vibrio counts, leading to better health, lower disease risk, and higher sustainability.

Anta®Catch: The industry’s first triple-action solution to address endotoxin challenges in livestock. Endotoxins cause substantial losses across dairy, poultry, swine, and aquaculture sectors. Anta®Catch not only binds toxins but also strengthens the intestinal barrier and reduces inflammation, offering a holistic solution to improve gut integrity and animal resilience.

These phytogenic products offer a game-changing approach to sustainable animal nutrition. With participation in leading global poultry and livestock exhibitions, Dr. Eckel is expanding its reach and showcasing its innovative solutions to diverse markets.

Jessica Rheindorf, Head of Marketing discussed about Dr. Eckel’s products availability in different part of world. Elisabeth Holl, Senior Technical Manager, updated on Dr. Eckel products. Muhammad Umar, Technical Sales Manager- Key Accounts gave a nice presentation on “Profitable Production and Sustainable Success- Your Phytogenic Solutions in Poultry”. Keerthana Giriprasad, Technical Sales, discussed about feed additive market. Ina Hickmann, Junior Marketing Manager updated us about their activities.

Growing Focus on India
With India’s poultry industry growing at 7–8% annually, the company sees immense potential for collaboration.
“Our solutions can support the sustainable growth of the Indian poultry sector,” said Bernhard Eckel.

“Together with our partners in India, we want to help farmers improve productivity through gut-health-focused, natural solutions,” added Dr. Antje Eckel.

Dr. Eckel is looking forward to working with strong partners to promote healthier animal farming practices in Indian poultry, dairy and aquaculture.

Those interested can contact the company directly (https://www.dr-eckel.de/en)